Osteoporosis in 2022: Care gaps to screening and personalised medicine (2022)
Attributed to:
Programme 3: Early development and risk of adult musculoskeletal disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.berh.2022.101754
PubMed Identifier: 35691824
Publication URI: http://europepmc.org/abstract/MED/35691824
Type: Journal Article/Review
Parent Publication: Best Practice & Research Clinical Rheumatology
Issue: 3
ISSN: 1521-6942